Published online Dec 24, 2021. doi: 10.5306/wjco.v12.i12.1202
Peer-review started: April 15, 2021
First decision: June 17, 2021
Revised: June 29, 2021
Accepted: November 18, 2021
Article in press: November 18, 2021
Published online: December 24, 2021
Processing time: 252 Days and 16.9 Hours
Gastric cancer (GC) is one of the most common malignant tumors worldwide. Tensin 4 (TNS4) is an adhesive protein belonging to the tensin family. This protein is located in focal adhesion sites. The TNS4 gene is considered an oncogene in numerous cancers. This protein plays an important role in adhesion, migration and proliferation of cells.
To evaluate expression of TNS4 protein in GC tissues and analysis of the clinical and histopathological parameters as well as the overall survival rate of patients.
The expression of TNS4 was assessed in 89 patients using immunohistochemistry.
Positive expression of TNS4 was observed in 49 of 89 patients (55.06%). Higher TNS4 expression was more common in GC tumors with a diameter ≥ 5 cm (P = 0.040). We demonstrated that an increase in TNS4 expression was more frequent in tumors of the histological type without mucinous components than in tumors from mucosal cancers (P = 0.023). Furthermore, TNS4 expression was higher in moderately differentiated tumors than in poorly differentiated and non-differentiated tumors (P = 0.002). Increased TNS4 expression was also noted in the intestinal type of GC according to Lauren’s classification (P = 0.020). No statistically significant correlation was found between the expression of TNS4 and the overall survival rate of patients.
TNS4 expression was significantly higher in tumors with a diameter ≥ 5 cm of the moderately differentiated intestinal type (according to Lauren’s classification) of GC without a mucinous component. Therefore, increased TNS4 expression is related to the histological type of GC with a better prognosis.
Core Tip: Tensin 4 (TNS4) is an adhesive protein belonging to the tensin family that plays an important role in cell adhesion, migration, and proliferation. These processes are important in cancer development and may limit cancer cell growth and improve patient survival. By applying immunohistochemistry, we investigated TNS4 expression in gastric cancer (GC) tissues and discovered that TNS4 expression was significantly higher in tumors with a diameter greater than 5 cm, in tumors of the moderately differentiated intestinal type (according to Lauren’s classification) and in GC without a mucinous component. We concluded that enhanced TNS4 expression was associated with the histological type of GC with a better prognosis.